<SEC-DOCUMENT>0001354488-11-002116.txt : 20110707
<SEC-HEADER>0001354488-11-002116.hdr.sgml : 20110707
<ACCEPTANCE-DATETIME>20110707151753
ACCESSION NUMBER:		0001354488-11-002116
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20110701
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110707
DATE AS OF CHANGE:		20110707

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AE Biofuels, Inc.
		CENTRAL INDEX KEY:			0000738214
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				261407544
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51354
		FILM NUMBER:		11956215

	BUSINESS ADDRESS:	
		STREET 1:		20400 STEVENS CREEK BLVD
		STREET 2:		SUITE 700
		CITY:			CUPERTINO
		STATE:			CA
		ZIP:			95014
		BUSINESS PHONE:		561-798-2907

	MAIL ADDRESS:	
		STREET 1:		20400 STEVENS CREEK BLVD
		STREET 2:		SUITE 700
		CITY:			CUPERTINO
		STATE:			CA
		ZIP:			95014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARWICH II LTD
		DATE OF NAME CHANGE:	19840123
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aebf_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
    <title>aebf_8k.htm</title>
    <!-- Licensed to: Issuer Direct Corp. -->
    <!-- Document Created using EDGARizerAgent 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>


<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">WASHINGTON, D.C. 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CURRENT REPORT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Date of Report (Date of earliest event reported): July 1, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">AE BIOFUELS, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nevada</font></div>
</td>
<td align="left" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">000-51354</font></div>
</td>
<td align="left" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">26-1407544</font></div>
</td>
</tr><tr>
<td valign="bottom" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or Other Jurisdiction</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of Incorporation)</font></div>
</td>
<td align="left" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Commission</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">File Number)</font></div>
</td>
<td align="left" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="19%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">20400 Stevens Creek Blvd., Suite 700</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cupertino, California 95014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address of Principal Executive Office) (Zip Code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(408)&#160;213-0940</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">N/A</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Former name or former address, if changed since last report)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font> Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item&#160;3.02 Unregistered Sales of Equity Securities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 1, 2011, AE Biofuels, Inc. (the &#8220;Company&#8221;) completed the acquisition of Zymetis, Inc., a Delaware corporation pursuant to Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) by and among the Company, AE Biofuels Americas, Inc., a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and Zymetis, Inc., a Delaware corporation (&#8220;Zymetis&#8221;), pursuant to which Merger Sub was merged with and into Zymetis with Zymetis surviving as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the Merger Agreement, the Company acquired all of the outstanding shares of capital stock of Zymetis in exchange for 6,673,555 shares of common stock of the Company (the &#8220;Merger Shares&#8221;).&#160;&#160;The Merger Shares are being issued in a transaction exempt from registration under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), by reason of Regulation D, Rule 506 promulgated thereunder.&#160;&#160;The Company does not consider the Merger to meet the reporting requirements as set forth in Item 2.01 of Form 8-K.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item&#160;7.01 Regulation FD Disclosure.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 6, 2011, the Company issued a press release announcing the acquisition of Zymetis, Inc., as disclosed under Item 3.02 of this Current Report.&#160;&#160;A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report and is incorporated herein by reference. The information contained herein and the attached exhibit are furnished under this Item 7.01 of this Current Report and are furnished to, but for purposes of Section 18 of the Securities Exchange Act of 1934 shall not be deemed filed with, the Securities and Exchange Commission. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated therein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Item 9.01 Financial Statements and Exhibits</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d) Exhibits</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="middle" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="66%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit No.</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="66%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font></div>
</td>
</tr><tr>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">99.1</font></font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press Release, dated July 6, 2011</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="middle" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AE Biofuels, Inc.</font></div>
</td>
<td align="left" valign="middle" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="middle" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="middle" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="58%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date:&#160;&#160;July 6, 2011&#160;</font></div>
</td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:&#160;&#160;</font></div>
</td>
<td align="left" valign="middle" width="24%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160; Eric A. McAfee</font></div>
</td>
<td align="left" valign="middle" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="middle" width="24%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Eric McAfee&#160;</font></div>
</td>
<td align="left" valign="middle" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="middle" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="middle" width="24%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Executive Officer</font></div>
</td>
<td align="left" valign="middle" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>aebf_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
<head>
    <title>aebf_ex991.htm</title>
    <!-- Licensed to: Issuer Direct Corp. -->
    <!-- Document Created using EDGARizerAgent 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>

<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-WEIGHT: bold">EXHIBIT 99.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><img src="aebf_logo.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">For Immediate Release</font></font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Media Contact:</font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investor &amp; Analyst Contact:</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Andy Foster</font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Todd Waltz</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(408) 213-0928</font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(408) 213-0925</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">afoster@aebiofuels.com</font></font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">twaltz@aebiofuels.com</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">AE Biofuels Announces Acquisition Of Industrial Biotechnology</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">Company Zymetis</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Company Expands Technology Portfolio to Include Production of Renewable Chemicals and Advanced Fuels by the Conversion of Existing Ethanol and Biodiesel Production Facilities</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CUPERTINO, Calif. &#8211; July 6, 2011 &#8211; AE Biofuels, Inc. (OTC: AEBF), a global advanced biofuels company, announced today that it has completed the acquisition of Zymetis, Inc., a Maryland-based industrial biotechnology company that develops products for the renewable chemicals and advanced fuels industries.&#160;&#160;Zymetis, Inc. will continue as a wholly-owned subsidiary of AE Biofuels.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Zymetis holds four granted patents and more than ten pending patents on the Z-microbe&#8482;, a marine organism that was originally discovered consuming plant cellulose at a high rate in the Chesapeake Bay. The genome of the Z-microbe has been fully sequenced by researchers at the University of Maryland. Zymetis&#8217; scientists discovered that the Z-microbe naturally generates about 90 enzymes that rapidly convert sugar, starch, and cellulose into useable chemicals and fuels.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By using the genetics of plants and microbes that naturally produce specialty chemicals, the Z-microbe has been converted to produce renewable chemicals and advanced fuels from renewable feedstocks.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Zymetis&#8217; technology has already demonstrated the production of high-value chemicals to supply multi-billion-dollar global markets, but we lacked a commercialization platform,&#8221; said Dr. Steve Hutcheson, founder of Zymetis and a 25-year genetic biology professor at the University of Maryland. &#160;&#8220;AE Biofuels has demonstrated operational global management capability, constructed and operated advanced biofuels plants, and has already achieved success in creating and adopting new technology through the conversion of first-generation biofuels facilities.&#8221;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;The combination of AE Biofuels and Zymetis enables the launch of new specialty chemical and renewable fuels products at an accelerated rate compared to the normal product development and construction cycle of three years or more,&#8221; said Eric McAfee, chairman and CEO of AE Biofuels, Inc.&#160;&#8220;The technical and chemicals business development team at Zymetis joins almost 100 global employees at AE Biofuels who currently operate 105 million gallons per year of biofuels plant capacity in the United States and India,&#8221; McAfee added.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">--more--</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20400 Stevens Creek Blvd., Suite 700, Cupertino, CA&#160;&#160;95014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(408) 213-0940</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">www.aebiofuels.com</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">AE Biofuels Announces Acquisition of Zymetis</font></div>
</td>
<td align="right" valign="top" width="42%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Page Two</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The technical team of Zymetis will join AE Biofuels in similar roles, and Zymetis founder Dr. Steve Hutcheson will join the board of directors of AE Biofuels.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AE Biofuels issued 6,673,555 common shares to Zymetis shareholders in the transaction, with 766,000 of the shares vesting over a three-year period.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">About AE Biofuels</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AE Biofuels, Inc. is a global advanced biofuels company based in Cupertino, California developing sustainable solutions to address the world's renewable chemicals and advanced fuels needs.&#160;&#160;The company operates a 55 million gallon ethanol plant in California and received a $1.8 million California Energy Commission grant to commercialize its patent-pending next-generation cellulosic ethanol technology that enables the production of advanced biofuels from both non-food and traditional feedstocks.&#160;&#160;The company&#8217;s wholly owned Universal Biofuels subsidiary built and operates a nameplate 50 million gallon per year biodiesel production facility on the east coast of India. For additional information about AE Biofuels, please visit <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.aebiofuels.com</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">About Zymetis</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Zymetis was founded in 2006 as a Maryland-based industrial biotechnology company to lead the way in bacterial reforming of complex biomass. Zymetis has engineered bacterium capable of converting whole plant materials into sugars that can then be used to make a range of commercially valuable products in the biochemical and biofuels industries. The company's flagship technology is the Zymetis Integrated Process (ZIP&#8482;) whereby strains of the organism and its enzymes are used directly in the processing of biomass into sugars tailored for a particular industrial process.&#160;&#160;For additional information about Zymetis, please visit <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.zymetis.com</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Forward Looking Statements</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained herein includes forward-looking statements. These statements relate to future events.&#160;&#160;Statements regarding future events are based on the parties' current expectations and are necessarily subject to associated risks related to, among other things, the ability of AE Advanced Fuels to successfully commercialize its cellulosic ethanol technology, changes in government policy regarding ethanol production, the reduction or elimination of federal tax incentives for ethanol production, and changes in environmental regulations. Actual results may differ materially from those in the projections or other forward-looking statements. For information regarding other related risks, please see the "Risk Factors" section of AE Biofuels&#8217; filings with the SEC, including its most recent filings on Forms 8-K and 10-Q.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">###</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20400 Stevens Creek Blvd., Suite 700, Cupertino, CA&#160;&#160;95014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(408) 213-0940</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">www.aebiofuels.com</font></div>
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>aebf_logo.jpg
<TEXT>
begin 644 aebf_logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`0$!
M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H*
M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`&X`
MY`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/WZ1$V#Y1T]*78G]T?E0GW!]*6@!-B?W1^5&Q/[H_*EHH`38G]T
M?E1L3^Z/RI:*`$V)_='Y4;$_NC\J6B@!-B?W1^5&Q/[H_*EHH`38G]T?E1L3
M^Z/RI:\U_:&_:C^&?[.OAN36?&&L1"8*?)M0XWN?3%;8?#U\555*E%RD]DC*
MM7I8>DZE65HK=L](<PQKND*J!U)XK$UGXD>`?#^1K'BBQ@(ZB2=17Y_Z_P#M
M6_ME?M@:U)H_P*\-W&DZ.[E5O60KE?7-;/A[_@EA\<O':C4_BO\`&F^\V7YI
M(XKAL#-?5+AC"X.*>98J--_RKWI?.Q\Y_K#B,6_^$_#RJ+^9^['Y7U?W'VI;
M?'CX/7<HA@\=Z:S$XP+A?\:Z'2_$?AW6D$FE:K;3J>ACD!KX?D_X(\6SP-)H
MOQAU(3(Q4M]H;AAU'7UKE=>_8R_;?_9XD;7OA5\3+G5H+?YOLLDI8D#VHCDG
M#V+]W"XY<W3F5D_F#S?.\.N;$8-\O]V2;^[0_1C:G]T?E1L3^Z/RKX9_9_\`
M^"G7B/P[XDB^&G[37AJ;2KW>(Q>2H55CTK[7\,^)]$\7:1#KGA_4([FVG0-'
M)$V00:\3-,FQ^4U%&O'1[-:I^C/7R_-<'F=-RHRU6Z>C7JMR_L3^Z/RHV)_=
M'Y4M%>4>B)L3^Z/RHV)_='Y4M%`";$_NC\J-B?W1^5+10`FQ/[H_*C8G]T?E
M2T4`)L3^Z/RHV)_='Y4M%`&?JBJ+@84?<';W-%+JG_'PO^X/YFB@"\GW!]*6
MD3[@^E+0`4444`%%%%`!1110`444DCK'&TC'`49)H`\V_:B_:&\.?L[?#.\\
M8ZS<H)EC(M82W+OC@5\1_L]_L]?$;]NWX@S?'/XW2W7_``C\4QDL=/.<2*#D
M``]:M?M7:_K/[8'[9.F_`G1KEWT?2;@->K&<J<'G-?>?PE\/^$O!GA6'P3X6
MCCA_LM%AN+8+M>-@/XA[]0>A'()K[2IB:7"F5TX0:6*Q"NF]XQ[+SMKZ'R,:
M,N(\SFYZX>B[6Z2EU;\EMZDWPU\#>!/!?ABUL/`NE6T-EY*F%X$`WJ1P:7X9
M:^=;\/RV<\F;C2K^?3[G/7=$Y52?JFQOQKF]-\4?\*U^*TOP^UJ39I6NL;O0
MYGX6&9B?,@SZ%\L!V+`=^,SP1K__``BG[1_B;P1<OM@U<)=VH/0RB,.V/J"_
M_?`K\(Q/&<7F>#G7E:3K3PM:+?PU)1YH/TFX+D?6-1/>Z/TJED[6&JQ@M%!5
M(/O%.S7RN[KO$Z[X5:Y_;D6O_/G[+XGO+<<]E8?XU8\%:ZOBK5]?OT(:VM=2
M%A!W#>4@+G_OX[C_`("*\`_9-_:E\'^-/A_\5O$OAR\#OX;\6W%NZLP/F3L-
MJ.,=49A@'OM/I7HOPW\8Z?\`"G]G:U\6ZXY>XNGFFAA9OFN)GD?:/Q`!)[`$
MUX62<9TO9X&&,G[-4Z-;$5F_LQC-TX7_`,3E)I=XJQZV;\.XO`8JO2E3:GSP
MIQCUO**F_P`+?^!&7^U!^R'\*/VC]*O-$N=*AAUF"W$B7<*`-&6SLR1W)!_+
MZ5\K?LR?'3XF_L4?&K_AGSXT74TNBW-QY>G7D['`&<#DU]Y_"K2=4TOPDFJ^
M)I-VJ:HYO=2<C&UW`PGL$0*N.VVOGO\`X*,?`+0OCI\(;KX@>#X0^IZ$QDMK
MZ%>)"G7:P^\`1C(XSWX-?O7!O$G]HX.E@<T5H8A7C&7Q0OK'YI-<]M$W;L?E
MW$63RPU:6.P'\2ENUM-+=/UL^7J?4FF:C::O81:E8S+)%,@>-U.0014]?,?_
M``3$^/\`<_%OX+1^']=N2VI:*WV><,>?EXKZ<KCS+`U<MQT\-4WB['J8#&4\
M?@X8B&TE<****X3K"BBB@`HHHH`****`*&J?\?"_[@_F:*-4_P"/A?\`<'\S
M10!>3[@^E+2)]P?2EH`****`"BBB@`HHHH`*P_B7K)\/>`]5UD-@V]E(X/T4
MUN5QWQ^@EN?@[X@AA^\=-EQC_=-;X:*GB81>S:_,RK-QHR:[,^+/^"5^@1^.
M/CAXU^+.JXDF-_)'$[<G[QZ5]J?%'P'K&LQIXM\":@;'Q#8(?LTRG"W,?4P2
M`\,I[9Z'TYKX^_X)`V>C:OHGC#P[K%G%/_Q,W\R*5<_Q'GV/OUKZC\6?#OXL
M^$MVJ_"'QW=3Q+R=%U:43C'I&\F3CV)'^]7%XQ5<0\76I5,).O12BOW,DJT+
M)6G"+Y;N+U3C+FOM%G+X?PA_9E*<:L83;;]]>Z[MW4GKOL[JWF<!\1?B5I?Q
M?\!OINNV?]D^*]`F,T<#Y43;>)50GE6P-VP\Y08S7@/[87[4FN?#CX;3_&"U
MOS;>([33(]/L+I2-TUXQ=$E'J0AW,._EMZUZ'\5O%&M^*?$!N?%OA2'3-8B&
MR]:*)HC-CH61B?FQ_$#R,>U?!_[>OBW5/BU\;?#O[.OA*;S#;3Q"X4'(^V7&
M`N[V2,@Y[>8WI7\%5L]S+B?C/V52LW"GRRJU.5TY35!\T)U(.W+5C?V<G'3M
MW?\`77AQPC@LPS&C"M!*E'FJ25U*,86O-*76$K*R??4YC]@#XQZ_\+?BR?`.
MLWD]OHWCJ&))HYLA9KB-G-M+SU^8R1CU,GM7Z7^&O%6G>,_$^AQ>+[U;/P[X
M7L(RT,AR'\M5S\H^\\DF.!SM^A-?`G[>_P`%+?X?>#/!GQ#\!Q-;_P#",QPZ
M2\T0PZ(GS6\A/J'5\GN9!7TC\#_B58_%WX7:)\08,'[?:*;R*-L;)U.V5/;#
MJP'M@URY_P`0U:L<-GV'7-1J-0J4Y-\K=*;G",K:\C=I2BK7MWU/L?$+`8+B
M7"T<^PT>3VO-3DUO&:7*G_BE322?1(^M]$\3>*OVCM<DM;*.?2O!]I)B[*MM
MFOS_`,\RPZ`CJ!T!Y)R,>F^(M`TNY\(7/AS[/%':M9F".$*`JKMP%`_I7BOP
MUU?X[>.M(M]#\`Z?9^&=!@0(EXEKU7N07R9&/))`'/4BO5_#?PVTWPO;MJ6J
MZM>:QJ(0E]0U2<R,IQSL4G$8^@SZDU_5'AKFN/S*@L:J52K4JV=3$U5[*#[1
MH0UG[./V5RPB]9.7,V?R7Q%A:&'FZ+E&,8Z1IQ?,UYSEMS/KJVMK61\,_P#!
M/>]G^&'[:'C+X71N4MIKAW2//`YK]#Z_.K]G'_B:?\%-O$EU8#]W&S!ROKDU
M^BHX%?T7QDD\PIU'O*G!OUL?F'"NF`J06T:DTO3F"BBBOD3Z<****`"BBB@`
MHHHH`H:I_P`?"_[@_F:*-4_X^%_W!_,T4`7D^X/I2TB?<'TI:`"BBB@`HHHH
M`****`"J'BG2DUSP[>Z3(N1<6SICZ@BK]!&1@TXMQDFN@FE)69^<?[$^KW7P
M._;'\6_!O5=3ETX:I<NUI,BID$G.0'!'Z5]8?'F(_#;PQ-XS^(7[5DGA_35R
M%>_58?,.,[$$)5I&Q_"JDGTKYZ_X*9_`WQ+X`\=Z7^U'\-K1_M&G3JU^(%Y*
M@Y.<5['^RCJ/[.O[4?A^S^+>M>%-/UWQ.D(2>XUX?;)+0C^&%9MRVZ^T84=S
MR23ZGB!PS@.,LNHYC4YW&45&?+5JP2DM-53E&]_,^8R'-,UR*O5RW"\BJ)N4
M'4BI+E>MTFFW9]$X^J/CWXJ?MG3"UU/Q+\.O!'B#Q9INFQ,]SXDO+2:.V5%_
MC)*LP7/]\IUKYN_9;^''[4OQT^*NL_M`?"/X;7FOW]K?RM<WD-JLD5O<3AC@
M;R`"$)`'8$>U?;7_``7F_:*@\$?!_P`/_LP^%[E8;KQ1<"_UF&$@>7I]NX\I
M"!T#S@$?]>["OHC_`()D?L[?\,U_L=^%_">HV/D:SK$']M:^&7#"ZN0K!&_V
MHXA%$?>,U_/63^&/"N!SZMA,-3O'E_>N3<G)RVB^9RTMOWZG](X;$<79!X)8
MS&9CF4EB\VFJ5"5*$*+HT*;O4E32N_?=X-R;=G%JQ\(?$O\`9_\`^"D_Q&\#
M:CX(\6_`N_N;'4(=DD:V%MN#`AE8;&R"&`/X5XS^QM\=_B7\(]3U;X*1?#:_
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M@73_`!+XC\(:'XDT75=.BN["74].BG1X)4#HZ[U.,J0<CFOB7]O+XO:=)]B_
M8\_9^N+R9+NY6.6W^W27(M4/'EHTC,RH.R9VKT4`<5^B>'GAAD^68ZG2P7/R
MJS<G6K.*BM=8N;AMY?(_$<XXEXFPF#J+.)TZDEHG&E&G-RVLXV>M]VI+_"BY
M_P`$K/"]]\0/C#XP^.=]"WEW5XZV\A'4;C7W_7D_[&_P%LO@!\&--\*)"%N6
MA5[IL<ER.:]8K[_B/'PS'-IU*?P*T8^BT1SY#@IX#+(4ZGQ/67J]6%%%%>$>
MP%%%%`!1110`4444`4-4_P"/A?\`<'\S11JG_'PO^X/YFB@"\GW!]*6D3[@^
ME+0`4444`%%%%`!1110`4444`97C/P=H?COP[=>&?$-FD]M=1%)$=<\$5^=_
MQ7^!WQQ_X)__`!3F^*7P9CN+WPU<3F2ZL8LD*N<GBOTEJGK>@Z3XCT^32]:L
M([B"52KQRH""/QKV\FSNKE4Y0E'GI3TE%[/_`()Y&:Y32S*,9)\E2.L9+=/]
M5W1^8NG_``O^!?[?W[3%G^T5\5OVBGLK^WOK`R>"[W05\@6MLR'[)YAG!VOA
M]S;?O2,0.<5^GFGZSI&I0+-IVH0RHP^4QR`C%?*OQ\_X)5_#'X@:A)XG^'5[
M+H.I,2P>U;:-WX5XY-^R+_P4*^$4IM_`/Q,EOK:,_NQ)*3Q790X<X3KU*E?+
MJZHRJ.\HSOOZZZ:G5FO&W'&-PN&PF<0=>GAH\E)TU%*,=-.5*.KLKMW;MJS]
M%6FB49,BCZFOF3_@I7^RS\'_`-K7X?Z)IOCWXLVWA2?PWJ,EU!JJV:W,AB>/
M;)"%,B8#$1L3SS&*\$;P1_P5/UH?V=-K?DJ?E,@.*O\`AW_@FA^TE\6+Y;WX
M[?%R[-NS9EMXYC@CTZU6(X2R:I0E3S#&0=-[J-VW]QS9/QMQ%DV94\=D^'J4
MZ]-WC)\J2=K=;IZ-JUF<EIO[5?BCX,?!?3?V-OV>?&]WXZN]-:2UL-?.F_9V
MBMF8E8B`[Y"%F`.1\NT8^7)]X_8,_82N_`-R?C+\8R;[Q)?GS?W_`,QB)Y[U
MZY^SY^Q+\&/V?;.,^'?#\4UZ`-]Y.@9R?7)KV%550%4``=`*6)S?`9?EZRW)
MX.%*UG)ZRDETOO8SGA<SSG-YYOG513KSDY622BI2=VTDDKM^2\D"J%`51@#H
M*6BBOESV@HHHH`****`"BBB@`HHHH`H:I_Q\+_N#^9HHU3_CX7_<'\S10!>3
M[@^E<]\6?BIX,^"7P[U7XJ?$/4)+31=%M_/U&YBMVE:./<%R$0%FY8<`$UT*
M?<'TKX/_`."WWQ?UW4?!W@S]C;X=EI]>^(FNP-=6D3?,]NDJI!$P["2Y9"#_
M`-.[5Y^:8W^S\!4KVNTM%W;T2^]H^HX+X=?%7$^&RQOEA.5YR_EIQ7-4E=Z*
MT$VKZ7L?4'[-/[8_P#_:ZM=7OO@5XIN-4BT.2&/47GTR:V\MI0Y0`2JI;(1N
MGI7<?$/QYX>^%_@;5_B-XNFFBTK0]/EOM2F@MVE:*")2\CA$!9MJ@G`!.!7Y
M=_LAV&L_\$R?^"H$W[-WBS6Y)O#?C.UM]/@OYAL2X\Y0]G/CID3[[?/0;WK]
M$OVSO^30/BI_V3G6_P#TAFKARO-,1B\NJ3K)*K3<E)=$UMUVM;J?3<9\%Y7D
M7%>$H9?4E4P.+C2J4INW,X3LI7=DN92YM+::71Y#_P`/H?\`@GO_`-%<U#_P
MEK__`.,T?\/H?^">_P#T5S4/_"6O_P#XU7R%_P`$L=/_`.";UU^SWJTG[7TG
M@$>)1XNN!9CQ3=(EQ]B^S6NS:&8'9YGFX/KNKZY^%_P&_P""1?QM\22^$?A#
M\//AQXDU&"R>[N+?1U$YAA5T0NY4D+\TB@`G)R<9P<>5@,SSW'X>%2%6@G)?
M"^:_W<Q]IQ/PCX:<+YIB<)7P68RC1DTZB=+D=NJDZ=K>9Z_J_P"UW\%?#WP"
MTG]IC7M6OK7PEK,,$MG>G399)`DW^J9XT#,H;CJ."0#BO//^'LW[#G_13[[_
M`,)N]_\`C5<__P`%./`WA;X9_P#!/:[\`^"-*2QTC2;W3;?3K*-B5@B6X7:@
M)).`.!DUY?\`LIW/_!+F/]GGPJOQJ3P,?%(T[_B<_P!I1,9_-WM]_`ZXQ7MU
M<5C(5U1YHI\J;;O:^SMJ?QWQ1Q-F>'XQJ9;EE6C2HJG[2+Q%[V<W%1O&23=D
MF].Y]'_#G_@I!^QQ\4O$]MX.\,?%V*/4+R416D.IZ=<6BS.3@('EC5-Q.``3
MDDX%>G?%KXK^#?@EX$O?B5\0;JXM]'TX*;VYM[1YS$K,%#%4!;&X@9`[U^:_
M_!0>T_8=\0:1X4T+]C32M+NO%=UK/ES1>%H)2)(&0A48=&D,ICV@?-PWM7V'
M^W+::_8?\$Z/$ECXJE+ZI#X6L$U)RV[=<"6W$ASW^;/-72QE=QJJ5FX*]UMM
ML<V5\69Q6P^90KNE4GAJ?/&I2NZ<FXRERN[>JMK9[/H>M_!3XW?#[]H+P/'\
M1OAA?W-WH\\\D4%W<64D'FLC;6VK(`2`P(SCJ#6=\<?VH_@1^SE917?Q?^(E
MGI4EPI:VL<--<S`<96&,,Y&>-V,9[UXK_P`$U_%UCX`_X)R67CO4T+6VBP:U
M?W"J>2D-Q/(P_)37@?[!7[-MK^WQ\1_%?[5'[3L\VM6D6K_9[;2S.ZQ3W&T2
M%&(((ABC>)5C!`.X9X!#-XVM*E2C!)SFK^2TNV;5.+,VK9=EM'!4XSQ>+@IZ
MW5."Y5*4G9MV5[)7N^_1_2/AG_@K-^Q5XCU=-)E\>ZAIOF/M2YU/19DA)]V4
M-M'NV!ZU]$:!X@T+Q7HUOXA\-:Q:ZA87<0EM+VRG66*9#T964D,/<5X_\1/^
M"=_[(/Q#\*S>&)/@IHVD.\)6WU+0;1;2YMVQPX=`-Q'7#A@>X-?-O_!,WQ9X
MZ_9[_:I\:?L.^,M:>\TZV>YFTHL3M2>%E;?&I^XLT#;RO8H.Y)-1Q&+H5HPK
MV:EHFK[]FGW-:.=\2Y+FV'PF=1ISIXA\D*E)27+.UU&49-_%T:^9[;\9_P#@
MK#^Q#^S[\3=6^#WQ8^(VHZ7X@T29(]1L?^$9O91&7C61"'CB*L&1T8$$\,*Y
MC_A^1_P3=_Z+-J7_`(26H?\`QFOC3XZ6W[/=W_P7O\3P?M2OH(\$E(O[5/B6
M54L]W_".P>3O+$`'S=F.?O8KZITWP;_P0CUO5;/0=!T[X.:A?ZC>PV=A8V%S
M'/-<3RR+''&B(Q9B691P.^3Q7ZWB.'^',!A<-*M1Q-252E"HW#EY4Y*[6L>G
MY'E8;B7BC,<9BH4<1A:<:56=-*IS*3479/26M[]M[GM/PE_X*(_LO_'#X6^,
M?C1\-?%&I7_AKP):_:/$6HG1+B,PH(GE<K$RB1]D:%CA>G3)R!U'[,G[6/P4
M_:_\'7OQ`^`^OW>J:/I^HFPGO;G2Y[53<!$D9%$RJ6PLB$D#'S"O/?CQ^S5\
M"_V<OV)?C?9_`_X;:=X9M]6^&NM2:A:Z6C)%*\>G7(5]N2`V&()'7`ST%>+?
M\&[7_)D'B#_LI=]_Z0V%>%5RO**^28K,,+SI0J0C%2:O:2UYK+5W6EK:=#Z*
MAF^=X?/\)EF,Y&ZE.<YN*E:\967+=Z*S5[IN_4^V_B'X[\/?"_P+J_Q'\6RS
M1Z5H6G37VI2V]NTSQV\2%Y'"("S;5!.`"<#I7&?LQ_M<_!#]L#PAJ'COX"Z_
M>:KI6F:B;&ZN[C2I[4?:!&LAC43(I8A'0G`Q\XJ3]LG_`)-#^*G_`&3C6_\`
MT@FKY'_X-S?^3,O%G_93KO\`]-VGUR87*L-6X:Q&82;YZ<X16UK2O>ZM>^FF
MIV8S.,70XKPV6Q2]G4ISD]'>\6K6=[6UUT/4M=_X+6_\$\O#.MWGAS7?BSJE
MM>Z?=26UY;OX2U#,4J,5=3B'&0P(_"JO_#\C_@F[_P!%FU+_`,)+4/\`XS7P
M?^P/9?L37W[9?QK7]MA_!XTM=6O?[$_X3"X2.+[1_:,N_P`LN1EMO7':OMGP
MA\+_`/@A]\0O%>G>!?`/AKX1ZWK.K7/D:?IFDS)<3S/M+8"(Q.`JL23P`.37
MUN:\/\+Y1B/8U*&*G:,9.4>3EUBI/5PZ7U/C,HXEXMSFA[:GB,)"\I149\_-
MI)Q6G/UZ'NGP>_;;^`7QW^"/B']HCX:ZYJ%[X3\,S7,>HW[Z3-&Y^SV\<\S)
M"R^8P5)!_#DE3@'@F[^S!^U_\"_VQ/#>I>+_`(">(KS5=-TF^%G>7=QI,]JH
MG*!]B^<BEB%92<#`W#UK!^(7P%^$/[/'['OQ1\'_``7\"V7A[2KSPIK-]-IV
MGJRP^>VG-&SJI)VY6),@8&03U)KYB_X-Q_\`DTOQI_V467_T@LZ^:_LO*\1D
MN,S"ASI4YPC!2:^&5[\UEJ].ED?4K-\WPV?8++<3R-U:<Y3<4_BC:W+=Z+7J
MFS]":P/B9\4_AS\&O!]U\0/BIXTT[0-&LE!N=1U2Z6*-2>B@G[S$\!1DD\`&
MM^ORE_X+\>*I+O\`:D^$'PY^*FJ:G:?#3[)'>ZNVGJ2Q+WIBO)$7H\L=LJ;<
MY(\PX^\<\G#63+/LWAA)2Y4TVVE=VBFVHKJW:R._BK/9<.Y+/&Q@I23BDF[*
M\FDG)]$KW?W'TMK/_!=C_@G;I.K-IEO\0]<OXU?:;VR\,7/D_4;U5B/HM>W_
M`+/W[;O[*W[45N9/@C\:='U>X4`R:8\K6]XF>,FWF"28SQG;C/>OEKP9XU_X
M-^-+\*P:#I-O\+7MC"$$FLZ!++=$8ZO+<Q&7=[DYKJOV2/V)/^"<DW[3MM^U
MA^QYX[T344TG2;F&3PWH^MK>06-Y-M1;I59VD@/E&=-C?*?,!4+MY]O,<KX>
MHX2HU0Q-&44^652*<9/HGHN6_=-V/GLLS?B:OC:<7B,)7C)KFC3DU**ZN.LN
M:W:RN?8.J?\`'PO^X/YFBC5/^/A?]P?S-%?#'Z&7=P2,,QP`O)-?C]XE\6_M
M:_ME?\%"?%/[4'['_P`/+?Q0/`.H)8Z#)?2V_P!EMK95EA@D`N)8U8N5FG4`
MDJSYP,"OU3^,7AW7OB1\*M=\`>$/&#>'M0UK2Y;*'6_L/VAK,2+L:18Q(F7"
MEMIW##8/.,'SC]@[]D'PU^P[\([SX9Z9XG_MZXU#69+^\U@Z6+62;*(BHR^;
M)PH3C!`^8\9))\#-\OQ.:8BC1NXTHMR<DU?F7PI;]==K'Z=P'Q3E/!F59ACW
M"%;&58QHTZ<XR</9S=ZTI6LM8I024D]7I;?\VOV]/AG_`,%/?'^E6?[1/[4W
MP:L]*A\&6ZQKKVBS62R01O.GE[Q!<.[!96!4@?*78].GWY:_M"V?[47_``2E
M\4_&&.9#>WWPIUF'6HTP/*OXK&:.=<=@74LH_NLI[U[O\5O"/A_XM?#/7_AC
MK\"M9Z_H]Q87'G0[U598V3=M#`G&<\$'(X(ZU\X?LV?\$YO$'[.O[/7Q%_9Q
ML_VA6U?1O'NFW%O$]SX5\LZ7-/;FWEF11=D2;H]ORG;\T:G/4'BI9/B\OQ]2
M5*4JD*L&I.35U)+W7TO=:;>I])CN/LAXJX9PE/'4J6%Q&!KPE1C2A-0E1FTZ
ML=YV<9+GU:NM(JY\P_\`!)S_`()W?LP?M:?LYZO\1_C3X<U&[U6S\8W&G02V
MFL2VZB!+6UD4;4(!.Z5^?<>E?<?[,_\`P3V_9L_9'\<WGC_X)Z5J=C>:AI3Z
M?>QW>JO<1R1&6.0'#Y(8&,8P1PQR#QCY+L/^""#Z3";;2OVRM7MHRVXQV_A3
M8I/`S@7O7@?E4_\`PXCU;_H]O7O_``F6_P#DVO/RS!8W+J%-?V=%U(KX^>";
M??O^)]/QCQ!PYQ7F.+FN+:L,+6DW[%T,1*$8Z6C:ZBTK7^%'T'_P5LN(+K]B
M/7);:9)%_MBP7<C`C(N5!''<$$'W%<%^QU_P3I_9'^+7[,O@_P"(WCOX<SW>
MKZMI?G7]RNN7<0D?S'&=J2A5X`Z`5Z/K_P"Q%-XD_8BT3]CF\^*9B&E&);CQ
M%_8QE>Y6*=Y5(B,R[&8E<Y9L8(YR"/%[?_@C'<V<"VMI^UIJ\42#"1Q^'2JJ
M/8"[XKZ&K1Q%3$*M*BI7BKIM:/=[[VVN?PUQ?D&*CQU5Q>'P$<?AE3]G%R<(
M7<9R:FHU+M7C;2UU>US*_P""A?['_P``?V0OAMH_QK_9^U/4?"GBJS\001Z<
MD&N2R-."KEF3S&9PRX!RIQC((.X5[+^T9\0=<^*W_!)^]^(_B>$)J.L^"]/N
MK[:FU6E::#<X'8,<L!Z&N!\*?\$8_`$?B6WU;XH?'G7O$5E`X+V,.FK:M*`<
M[#*TTA"GOM`..A!YKZ:^/7P/TOXQ?L^7_P"SWX;U:+PYIUY8P644T>F^>MM;
MQ,C*B1B1,8$:J,G`'8U5+"U[57R*"E&RBFM^_8X<LX>SGES*K'"1PL*U%PA1
MC.+3GRM<[Y;03=[=//8\8_X)^>#)_B-_P3";X>VL@277=,U[3XW8\*TTMQ&"
M?Q:O.O\`@CE\</#?@.T\4?LM?$&Z31_$*^(I+W3[2_81M/+Y:03VXS_RT0P*
M=G4ACC.TX^IOV2?@;_PRY\&;/X./XO\`[=@L+J>6VOAIGV9BLLC2%67S7!(9
MFY!'&..,GSG]J[_@F[\#OVG/$,GC^RU"]\*^)YL?:=5TV!)(KLC@/-"2-S@`
M?,K*3W)P,7]5Q%.G1J4U[\%9KOHKZG4^'L^P.!RK'X*$98G"TE3G3E))3BXI
M22DKI--73V_)_1/BSQAX7\"^'KKQ9XQU^TTS3;&$RW=]>SK''$@ZDD_Y/2O@
M/]A2_N?VF?\`@I1XX_::T"PE30+"&Y>"YDC*[A(JVULI'9FB1W([;36O9?\`
M!'/6-=O8+?XH_M9:WJ^E6S`I9PZ2P?'^RTUQ(L9QWV-7UW\"O@O\*?V<O`</
MP[^%?APV-C&YDGD<[YKJ4@!I97/+N<#GH``````*Y,5BZT)5(\D8N^]VWTV.
ME83B/BC-L+6Q^&6&P^'G[2W/&<YS2:C\.BBKMZZO\OR_^,?P`^&O[3__``7[
M\2?!?XN:;<7F@ZJD3WD%K=O`[&+PY#*F'0@C#HI]^E?8_A+_`((H?L(>`O&&
MC^/?!WA#7K+5M"U>UU+3;D^(YY`D\$R2IE7)5E+(`01T)Z=:DTS_`()TO8?\
M%&+C_@H.WQI#W=Q*P;PN/#.(Q$=/%B%$_P!J)W!`&W;,%L_*!P/JC^U+?^X_
MY#_&OTW/.*L5.CA:.7XF:A"A3A-)RBN=)J2MI?2VNS-.'^#\'&MC*^986$JD
M\14G"349/D;3BTU>VMW;1H\^_;-TR^UO]D#XJZ+IENTMS=_#C6X;>)!DN[6$
MP50.Y)(KX^_X-T/'7A:[_96\6_#J+6(/[9L/'<U]<:?YH\T6TUG:)'+MZ[2\
M,JY]4-?H#)J%G-&T4L+,K`AE9001Z5^??QQ_X(,_"?Q-\0KKXD?LV_'/6_AM
M<7<[S-IL&G_:K>W=CEE@*30R0I_LEG`Z#`P!S9%C<IJY-B,KQU5TO:2A.,U%
MR2<;III:ZIZ6.SB+`9Q1SS#9QE])5G3C.$H.2@VI6::;TT:U3_X;ZP_;Y\;^
M%O`7[%WQ0UKQ9K5O903>!=4M(&GE"^;<3VLD4,2YZN\CJH'<FOF7_@W8TR^L
MOV*/$=Y=6[)'>?$F\DMG8<2(+&Q0L/4;E8?4&N$TS_@@-JOBS6;>Y^/O[;OB
M7Q)I\#@FSM]'99B.^V:XNIA&2.,^6:^_O@G\*/AE^SQ\+=)^#WPE\._V9H>C
M6YBL[<'>Q))9Y'8G+NSLS,QY)8UMC\3DN5\.SRW!UW7G5G&4I<CA&*BG9>]J
MVV_0Y\MPN>YOQ-3S7&X=8>G2IRA&//&<I.35W[NB22]?T_)?_@GC^QC\!?VS
M?VS_`(W>%_CSH=Y?6FC:K>75@EGJ4EL5D;4948DQD%ACL:^_/@[_`,$A/V*O
M@'\4M#^,?PL\,ZU8:[X?O#<6,\OB":="2C1LK)(2""KGW]#7SCXF_P""`3^(
M?'.M^/;;]LS4M-NM<U.XO;J/3_!OEJK2RM(5!%]DJ"QQG-5_^(?G6/\`H_/Q
M'_X2S?\`R?7TV<9SEN:UG*EG$Z5.48Q=/V=5QTBHR6EDT];Z'R>29'FV445&
MKDD*U6,Y251U*2EK)RCT;5M+:]#[W_:EN;>7]F7XE113([1>!=7$BJP)4FQE
M.#Z<$'\:^-?^#<DA?V3/&@)Q_P`7%E_](+.O9?V5?V`]3_9G_9:^(/[-<_QM
MF\0R>-;F]DB\17NBE7M5N;"&T(:$W#;ROEEA^\&<@<8KYDTS_@WA.BPM;Z/^
MV]K5I&S;FCMO"'EJ6QC)"WPYX%>#EL^'H93C,LK8SE4YP<9^SF^913O[JU6_
M5GT6:4^):F<X'-J.!YI0IU(SA[6"Y7)I)<ST>U]$?I_O3^\/SKY^_;1M/V&O
MBWJW@K]GO]K6RT:^E\827<OA*6]O?L[121(A=H[E'1HB^]%4!L2'"X.,5\E?
M\0_.L?\`1^7B/_PEF_\`D^O;OCA_P2)^!'[1GP6\!>"?B+XPUVU\5>!/!.G^
M'K3Q5I,Y\N>.VA5,M:RLT>UGW/\`+M?YL%R`*X*.#X<R_&TJE/,925W>4*<H
MR@[>[+5JZONEK8]"OCN*,SP-6E4RR$796C4JPG&:YES1T6CMLWI?T,K4O^"`
M?[`6H%Y;3_A,[-7Y46OB16"_3S(F_7-?&&@_!W1/V#?^"QO@#X2?LO?%6^\1
M6,^NZ9:ZL&G22>W@NY3%=V5R8@J2%(?WI^4;<H2`RYKW&/\`X(+_`!?LH/\`
MA'-(_P""A>NPZ+]U;,>'KA55/[OEKJ&P\?2OH?\`89_X)0?LY?L2^)!\2K34
MM2\6^,1"T4&OZQ$B)9*Z[7^SP*2(V925+LSM@D!@&8'ZN/$F&R[!UU7S.>,5
M2$HJFX22O)64I.>UO+4^/EPOB\TQN'^KY5#!.G4C.515(MVB[N,8PWOYZ'U-
>JG_'PO\`N#^9HJOJ>I0&<$(_W/0>I]Z*_)3]I/_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
